Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  New England Journal of Medicine

• Publication date

  1980-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198011203032102PMID 7421945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The incidence of femoral neck fractures in New Zealand.

  1980cited by this paper
• Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

  1979cited by this paper
• Endometrial cancer in relation to patterns of menopausal estrogen use.

  1979cited by this paper
• POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS: A Case-control Study

  1979cited by this paper
• BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT

  1978cited by this paper
• Prospective trial of oestrogen and calcium in postmenopausal women.

  1977cited by this paper
• Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.

  1977cited by this paper
• Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

  1976cited by this paper
• Estimability and estimation in case-referent studies.

  1976cited by this paper
• LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN

  1976cited by this paper
• ESTROGENS AND POSTMENOPAUSAL OSTEOPOROSIS

  1976cited by this paper
• Incidence of Fractures in Persons over 35 Years of Age

  1964cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Updated Labeling for Menopausal Hormone Therapy.

  2025cites this paper
• Uncovering Racial and Genetic Disparities in FRAX Performance for Fracture Risk Assessment in Postmenopausal Women.

  2025cites this paper
• Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women

  2023cites this paper
• Osteopathy in mild adrenal Cushing's syndrome and Cushing disease.

  2021cites this paper
• Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro.

  2021cites this paper
• The Use of Pharmacoepidemiology to Study Beneficial Drug Effects

  2019cites this paper
• Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.

  2019cites this paper
• Osteoporose: Entstehung, Prophylaxe und Therapie

  2019cites this paper
• Estradiol-Loaded Poly(ε-caprolactone)/Silk Fibroin Electrospun Microfibers Decrease Osteoclast Activity and Retain Osteoblast Function.

  2018cites this paper
• Beta-cyclodextrin modified mesoporous bioactive glass nanoparticles/silk fibroin hybrid nanofibers as an implantable estradiol delivery system for the potential treatment of osteoporosis.

  2018cites this paper
• Impact of frequent apheresis blood donation on bone density: A prospective, longitudinal, randomized, controlled trial

  2018cites this paper
• A FAMILY MEDICINE PRACTICE, ESTIMATING THE PREVALENCE OF OSTEOPENIA / OSTEOPOROSIS IN PATIENTS HAVING LIVER CIRRHOSIS IN KSA

  2018cites this paper
• Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women

  2017cites this paper
• DEFERRING MENOPAUSE BY THE ADMINISTRATION OF A LUTEINIZING (56) References Cited HORMONE ANTAGONST U.S. PATENT DOCUMENTS

  2017cites this paper
• Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive

  2017cites this paper
• A Survey of Older Women's Attitudes

  2017cites this paper
• Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making

  2017cites this paper
• Postmenopausal Osteoporosis.

  2016cites this paper
• Causes of venous thrombosis

  2016cites this paper
• Impact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women

  2016cites this paper
• Systems Biology Approaches For The Analysis Of High-Throughput Biological Data

  2016cites this paper
• Prophylaxis of Osteoporosis with Estrogens

  2015cites this paper
• Menopausal Hormone Therapy and Chronic Disease Risk in the Women's Health Initiative: Is Timing Everything?

  2014cites this paper
• Trends of Postmenopausal Estrogen Plus Progestin Prevalence in the United States Between 1970 and 2010

  2014cites this paper
• Microarray Gene Expression Profiling of Bisphosphonate-Treated Normal Human Oral Keratinocytes

  2014cites this paper
• Analysis and correction of crosstalk effects in pathway analysis

  2013cites this paper
• Estrogen and Estrogen Analogs for Prevention and Treatment of Osteoporosis

  2013cites this paper
• An Overview of the Extent and Nature of Menopause and Its Physiological Basis

  2013cites this paper
• The Health Benefits Of Smoking Cessation: A Report Of The U.S. Surgeon General 1990

  2012cites this paper
• Modulation of Immune Senescence by Menopause and Hormone Therapy

  2012cites this paper
• The history of hormone therapy use and recent controversy related to heart disease and breast cancer arising from prevention trial outcomes.

  2012cites this paper
• The WHI: the effect of hormone replacement therapy on fracture prevention

  2012cites this paper
• Safety of drugs used in the treatment of osteoporosis

  2011cites this paper
• EFFECT OF PPARγ HIS447HIS POLYMORPHISM ON OOCYTES AND FERTILIZATION IN IVF

  2011cites this paper
• Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy

  2011cites this paper
• Two common polymorphisms in the peroxisome proliferator-activated receptor γ gene may improve fertilization in IVF.

  2011cites this paper
• Collagène hydrolysé et santé osseuse

  2010cites this paper
• Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture.

  2010cites this paper
• POSTMENOPAUSAL OSTEOPOROSIS : A PERSONAL APPRECIATION

  2010cites this paper
• Systemic Effects of Vaginally Administered Estrogen Therapy: A Review

  2010cites this paper
• Glycitein decreases the generation of murine osteoclasts and increases apoptosis

  2010cites this paper
• Managing Menopause: An Ethnographic Study of Women's Midlife Information-Seeking and Decision-Making in the Southwest U.S.

  2010cites this paper
• Osteoporotic Fragility Fractures

  2009cites this paper
• Medical Treatment of Age-Related Osteoporosis: Present and Future

  2009cites this paper
• Hormone Replacement Therapy: Real Concerns and False Alarms

  2009cites this paper
• Progress in osteoporosis and fracture prevention: focus on postmenopausal women

  2009cites this paper
• Causes of Venous Thrombosis

  2009cites this paper
• Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice

  2009cites this paper
• Évaluation de l'utilisation des agents prévenant la résorption osseuse en situation réelle et impact de la non-adhésion au traitement sur la survenue de fractures ostéoporotiques : l'utilisation et les coûts directs des soins de santé

  2008cites this paper
• [Obesity and endocrine functions. Sex hormones].

  2008cites this paper
• Long-term impact of the women’s health initiative on HRT

  2008cites this paper
• ASHP Therapeutic Position Statement on the Prevention and Treatment of Osteoporosis in Adults

  2008cites this paper
• CHAPTER 72 – Estrogen Therapy: Prevention and Treatment of Osteoporosis

  2008cites this paper
• CHAPTER 25 – Epidemiologic Methods in Studies of Osteoporosis

  2008cites this paper
• postmenopausal women . community-based mineral density among hormones and bone Endogenous sex

  2008cites this paper
• Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.

  2008cites this paper
• Einfluß einer niedrigdosierten Hydrochlorothiazidtherapie auf den Knochenmineralgehalt des axialen und peripheren Skeletts

  2008cites this paper
• TREATMENT OF OSTEOPOROSIS

  2007cites this paper
• Interventions for Osteoporosis

  2007cites this paper
• Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates

  2007cites this paper
• Hormone Replacement Therapy Update - 2007

  2007cites this paper
• Historical perspectives in postmenopausal hormone therapy: defining the right dose and duration.

  2007cites this paper
• The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: Lessons learned from the women’s health initiative

  2007cites this paper
• Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy

  2007cites this paper
• Lifelong calcium intake and prevention of bone fragility in the aged

  2007cites this paper
• Serum from Postmenopausal Women Directs Differentiation of Human Clonal Osteoprogenitor Cells from an Osteoblastic toward an Adipocytic Phenotype

  2007cites this paper
• The Menopause: A Signal for the Future

  2007cites this paper
• Role of oestrogen in the development of osteoporosis

  2007cites this paper
• Hormone replacement therapy cohort study in breast cancer survivors : A

  2006cites this paper
• A Controlled Therapeutic Trial in 70-year-old Women

  2006cites this paper
• Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.

  2006cites this paper
• Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy

  2006cites this paper
• Cost-effectiveness of alternative treatments for women with osteoporosis in Canada

  2006cites this paper
• CHAPTER 37 – Laboratory Assessment of Postmenopausal Osteoporosis

  2006cites this paper
• Preventive trial on postmenopausal hormone therapy in Estonia : A study of treatment preferences and trial process within a changing environment

  2006cites this paper
• Laboratory Assessment of Postmenopausal Osteoporosis

  2006cites this paper
• Raloxifene reduces fractures in postmenopausal women with osteoporosis.

  2006cites this paper
• The Effect of Estrogens in Prévention and Treatment of Osteoporosis

  2006cites this paper
• Skeletal Consequences of Hormone Therapy Discontinuance: A Systematic Review

  2006cites this paper
• The Risk of Gynecological Cancers Associated With Different HRT Formulations. A Nested Case-Control Study in the German Cohort Study on Women's Health - Gynecological Tumors and HRT Use

  2006cites this paper
• Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial

  2006cites this paper
• Breast cancer risk associated with different HRT formulations: a register-based case-control study

  2006cites this paper
• Panel Session: Prevention/Treatment Hormonal Therapy in Climacteric Women: Compliance and Its Socioeconomic Impact

  2006cites this paper
• Special Topic: Risk Factors Risk Factors For Osteoporosis and Associated Fractures

  2006cites this paper
• Fracturein the Undertreatment of Osteoporosis Following Hip

  2006cites this paper
• Regular Re viezv Postmenopausal osteoporosis

  2006cites this paper
• Hip fracture mortality and morbidity in Switzerland and Japan: A cross-cultural comparison

  2005cites this paper
• Abstracts at the 36th Kansai calcium conference April 27, 1996 Restaurant Palace, New Hankyu Building, Osaka, Japan

  2005cites this paper
• Genistein derivatives as selective estrogen receptor modulators: sonochemical synthesis and in vivo anti-osteoporotic action.

  2005cites this paper
• Is dehydroepiandrosterone a hormone?

  2005cites this paper
• Gonadal hormones

  2005cites this paper
• Diagnosis , Treatment , Prognosis , and Rehabilitation in Women With Coronary Heart Disease Chest Pain

  2005cites this paper
• Risks and Benefits of Estrogen Therapy

  2005cites this paper
• Hormone replacement therapy in women with spinal cord injury – a survey with literature review

  2005cites this paper
• Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women

  2005cites this paper
• Clinical appraisal of the Women's Health Initiative

  2005cites this paper
• A Pilot Study to Examine a Combination Botanical for the Treatment of Menopausal Symptoms

  2005cites this paper
• Screening for osteoporosis by bone densitometry: A stratified intervention approach

  2005influential citation
• Venous thrombosis: the role of genes, environment, and behavior.

  2005cites this paper
• How to manage osteoporosis after the menopause.

  2005cites this paper